INFED is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc.. The primary component is Iron Dextran.
Product ID | 0404-9879_07d004e6-7f78-4f1f-b671-7003c5b3c3c4 |
NDC | 0404-9879 |
Product Type | Human Prescription Drug |
Proprietary Name | INFED |
Generic Name | Iron Dextran |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2022-01-11 |
Marketing Category | NDA / |
Application Number | NDA017441 |
Labeler Name | Henry Schein, Inc. |
Substance Name | IRON DEXTRAN |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-01-11 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0023-6082 | INFeD | Iron Dextran |
0404-9879 | INFED | iron dextran |
52544-931 | INFeD | Iron Dextran |
52584-086 | INFED | iron dextran |
52584-931 | Infed | Iron Dextran |
51662-1441 | IRON DEXTRAN | IRON DEXTRAN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INFED 74185675 1717425 Live/Registered |
ALLERGAN SALES, LLC 1991-07-16 |